Christopher Durant Turner
CIK 1862146 · Chief Medical Officer · last filed 2026-01-07
Christopher Durant Turner is a Chief Medical Officer who has filed 10 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for NUVL, was dated Jan 7, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.95M
1
10
-$2.19M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUVL | Chief Medical Officer | 72,630 | $123.25 | $8.95M | -$2.19M | 10 | 2026-01-07 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-07 | NUVL | Mixed | +10,083 | -$721.3K | EDGAR |
| 2025-01-08 | NUVL | Mixed | +14,734 | -$320.0K | EDGAR |
| 2024-01-09 | NUVL | Grant (A) | +33,300 | $0 | EDGAR |
| 2023-10-06 | NUVL | Mixed | — | -$376.9K | EDGAR |
| 2023-07-28 | NUVL | Mixed | — | -$206.5K | EDGAR |
| 2023-07-24 | NUVL | Mixed | — | -$12.0K | EDGAR |
| 2023-06-07 | NUVL | Mixed | — | -$388.6K | EDGAR |
| 2023-01-06 | NUVL | Grant (A) | — | $0 | EDGAR |
| 2022-05-19 | NUVL | Exer (M) | +14,513 | $100.0K | EDGAR |
| 2022-01-05 | NUVL | Grant (A) | — | $0 | EDGAR |